149 related articles for article (PubMed ID: 15800866)
41. The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells.
Lu H; Ma F; Wang H; Geng PS; Wang SS; Wang JG; Wu CC; Zhao BY
Toxicon; 2015 Jun; 99():44-50. PubMed ID: 25797317
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of sulfamide-type indolizidines as glycosidase inhibitors.
Benltifa M; García Moreno MI; Ortiz Mellet C; García Fernández JM; Wadouachi A
Bioorg Med Chem Lett; 2008 May; 18(9):2805-8. PubMed ID: 18420407
[TBL] [Abstract][Full Text] [Related]
43. Glycosidase inhibition by cyclic sulfonium compounds.
Yuasa H; Takada J; Hashimoto H
Bioorg Med Chem Lett; 2001 May; 11(9):1137-9. PubMed ID: 11354361
[TBL] [Abstract][Full Text] [Related]
44. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and SAR of highly selective MMP-13 inhibitors.
Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
[TBL] [Abstract][Full Text] [Related]
46. Characterization and subcellular localization of human neutral class II alpha-mannosidase [corrected].
Kuokkanen E; Smith W; Mäkinen M; Tuominen H; Puhka M; Jokitalo E; Duvet S; Berg T; Heikinheimo P
Glycobiology; 2007 Oct; 17(10):1084-93. PubMed ID: 17681998
[TBL] [Abstract][Full Text] [Related]
47. A practical synthesis of kifunensine analogues as inhibitors of endoplasmic reticulum alpha-mannosidase I.
Hering KW; Karaveg K; Moremen KW; Pearson WH
J Org Chem; 2005 Nov; 70(24):9892-904. PubMed ID: 16292820
[TBL] [Abstract][Full Text] [Related]
48. A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Liu J; Cao R; Yi W; Ma C; Wan Y; Zhou B; Ma L; Song H
Eur J Med Chem; 2009 Apr; 44(4):1773-8. PubMed ID: 18524420
[TBL] [Abstract][Full Text] [Related]
49. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.
Peukert S; Sun Y; Zhang R; Hurley B; Sabio M; Shen X; Gray C; Dzink-Fox J; Tao J; Cebula R; Wattanasin S
Bioorg Med Chem Lett; 2008 Mar; 18(6):1840-4. PubMed ID: 18295483
[TBL] [Abstract][Full Text] [Related]
50. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies.
Ragno R; Simeoni S; Rotili D; Caroli A; Botta G; Brosch G; Massa S; Mai A
Eur J Med Chem; 2008 Mar; 43(3):621-32. PubMed ID: 17698257
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, crystal structure and biological activity of beta-carboline based selective CDK4-cyclin D1 inhibitors.
García MD; Wilson AJ; Emmerson DP; Jenkins PR; Mahale S; Chaudhuri B
Org Biomol Chem; 2006 Dec; 4(24):4478-84. PubMed ID: 17268643
[TBL] [Abstract][Full Text] [Related]
52. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
[TBL] [Abstract][Full Text] [Related]
53. Piperidines: a new class of urease inhibitors.
Khan KM; Saify ZS; Arif Lodhi M; Butt N; Perveen S; Maharvi GM; Choudhary MI; Atta-Ur-Rahman
Nat Prod Res; 2006 May; 20(6):523-30. PubMed ID: 16835082
[TBL] [Abstract][Full Text] [Related]
54. Binding of sulfonium-ion analogues of di-epi-swainsonine and 8-epi-lentiginosine to Drosophila Golgi alpha-mannosidase II: the role of water in inhibitor binding.
Kumar NS; Kuntz DA; Wen X; Pinto BM; Rose DR
Proteins; 2008 May; 71(3):1484-96. PubMed ID: 18076078
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
[TBL] [Abstract][Full Text] [Related]
56. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
Coutrot P; Claudel S; Didierjean C; Grison C
Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
[TBL] [Abstract][Full Text] [Related]
57. Alpha- and beta-glycosyl sulfonium ions: generation and reactivity.
Nokami T; Shibuya A; Manabe S; Ito Y; Yoshida J
Chemistry; 2009; 15(10):2252-5. PubMed ID: 19156648
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of monoterpene cyclases by sulfonium analogs of presumptive carbocationic intermediates of the cyclization reaction.
Croteau R; Wheeler CJ; Aksela R; Oehlschlager AC
J Biol Chem; 1986 Jun; 261(16):7257-63. PubMed ID: 3011779
[TBL] [Abstract][Full Text] [Related]
59. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
Hu Y; Xiang JS; DiGrandi MJ; Du X; Ipek M; Laakso LM; Li J; Li W; Rush TS; Schmid J; Skotnicki JS; Tam S; Thomason JR; Wang Q; Levin JI
Bioorg Med Chem; 2005 Dec; 13(24):6629-44. PubMed ID: 16216515
[TBL] [Abstract][Full Text] [Related]
60. Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors.
Popowycz F; Gerber-Lemaire S; Demange R; Rodriguez-García E; Asenjo AT; Robina I; Vogel P
Bioorg Med Chem Lett; 2001 Sep; 11(18):2489-93. PubMed ID: 11549453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
